Literature DB >> 23178415

Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services.

Ashley R Branham1, Aaron J Katz, Joseph S Moose, Stefanie P Ferreri, Joel F Farley, Macary W Marciniak.   

Abstract

OBJECTIVE: To compare the estimated cost avoidance (ECA) of pharmacist-provided medication therapy management (MTM) services among common disease states encountered in community pharmacy practice.
DESIGN: Retrospective analysis.
SETTING: Nine community pharmacies in North Carolina. PATIENTS: Three hundred and sixty-four patients who are 65 years of age or older, a Medicare Part D beneficiary and a North Carolina resident.
INTERVENTIONS: An MTM pharmacist-provider conducted medication reviews to eligible patients between July 2009 and October 2009. For each encounter, patient interventions, pharmacist recommendations, and ECA were recorded. MAIN OUTCOME MEASURE: ECA.
RESULTS: In 9 pharmacy locations, 634 MTM interventions were documented during the study period. The ECA in a 4-month period yielded approximately $494 000. Comprehensive medication reviews, new prescription counseling and appropriate medication administration, and technique counseling made up nearly two-thirds of interventions. Overall, the probability that an MTM intervention would result in an ECA greater than $0 was .35.
CONCLUSIONS: Pharmacist-provided MTM effectively reduced costs associated with patient medication use. Such interventions reduced costs in overall health care specifically in the areas of cardiovascular, gastroesophageal reflux disease, pulmonary, and diabetes groups.

Entities:  

Keywords:  community pharmacy; estimated cost avoidance; medication therapy management

Mesh:

Year:  2012        PMID: 23178415     DOI: 10.1177/0897190012465992

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  6 in total

1.  Establishment and Implementation of a Required Medication Therapy Management Advanced Pharmacy Practice Experience.

Authors:  Wesley Nuffer; Eric Gilliam; Megan Thompson; Joseph Vande Griend
Journal:  Am J Pharm Educ       Date:  2017-03-25       Impact factor: 2.047

2.  Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study.

Authors:  Brett MacFarlane; Andrew Matthews; Jenny Bergin
Journal:  Int J Clin Pharm       Date:  2015-05-14

3.  Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Christina A Spivey; Samuel Dagogo-Jack; Jim Y Wan; Shelley I White-Means; William C Cushman; Marie A Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2014-06

4.  Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence.

Authors:  Hayden B Bosworth; Leah L Zullig; Phil Mendys; Michael Ho; Troy Trygstad; Christopher Granger; Megan M Oakes; Bradi B Granger
Journal:  JMIR Med Inform       Date:  2016-03-15

5.  EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies.

Authors:  Elsa López-Pintor; María Puig-Moltó; Blanca Lumbreras
Journal:  Int J Environ Res Public Health       Date:  2022-08-09       Impact factor: 4.614

6.  Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI).

Authors:  Bradi B Granger; Melodie Staton; Lindsay Peterson; Shelley A Rusincovitch
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2015-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.